Trial Profile
A randomized, double-blind, placebo- and active-controlled, multiple ascending-dose study to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of mirogabalin in healthy elderly subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Feb 2016
Price :
$35
*
At a glance
- Drugs Mirogabalin (Primary) ; Pregabalin
- Indications Neuropathic pain; Postherpetic neuralgia
- Focus Pharmacodynamics; Pharmacokinetics
- 02 Feb 2016 New trial record